Welcome to our dedicated page for Astronics SEC filings (Ticker: ATRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Astronics Corporation files regular SEC disclosures that detail financial performance across its Aerospace and Test Systems segments. The company's 10-K annual reports break down revenue and operating income by business segment, revealing which product lines drive profitability. For investors analyzing aerospace suppliers, these segment disclosures show whether growth comes from commercial aviation, military programs, or test equipment sales.
Quarterly 10-Q filings track how aircraft production rates and airline retrofit activity affect Astronics' business. The reports include backlog figures that indicate future revenue under contract, plus discussion of major program wins or losses. Manufacturing costs, engineering expenses, and certification investments appear in detailed financial statements that explain margin trends across product lines.
Form 8-K filings announce material events such as credit facility amendments, acquisition closings, or significant contract awards. These disclosures often precede detailed discussion in quarterly reports. DEF 14A proxy statements reveal executive compensation structures and governance matters. Form 4 filings track insider transactions, showing when executives and directors buy or sell shares.
Our platform provides AI-powered summaries that extract key metrics from lengthy aerospace industry filings. Identify revenue trends by segment, understand how contract accounting affects reported earnings, and monitor insider trading activity without reading hundreds of pages of technical financial documentation. Track certification costs, warranty reserves, and inventory levels that indicate operational performance in specialized aerospace manufacturing.
Astronics Corp insider Peter J. Gundermann, the company’s President, CEO and a director, reported a new grant of 29,750 stock options on December 4, 2025. The options have an exercise price of $51.72 per share, become exercisable on December 4, 2026, and expire on December 4, 2035, and relate to $.01 par value common stock.
After the reported transaction, he directly owned 83,906.608 shares of $.01 par value common stock and 747,911 shares of $.01 par value Class B stock. The filing also lists multiple existing option grants and restricted stock units, each RSU representing the right to receive one share of common stock at settlement. Several RSU awards for 9,206, 26,450 and 25,250 shares may vest in 2026, 2027 and 2028 based on Astronics’ average annual adjusted EBITDA over the periods January 1, 2023–December 31, 2025, January 1, 2024–December 31, 2026, and January 1, 2025–December 31, 2027, with vesting ranges between 75% and 115% or between 50% and 150% of target depending on the grant.
Astronics Corp executive James Mulato, President of Astronics Test Systems, reported a stock transaction and updated his equity holdings. On 12/01/2025, he sold 9,734 shares of $.01 par value common stock at $53.24 per share. After this sale, he directly holds 27,077.822 shares of common stock and 2,453 shares of Class B stock.
He also reports a broad set of stock options on Astronics common and Class B stock, with exercise prices ranging from $9.74 to $35.61 and expiration dates from 2026 through 2033. In addition, he holds performance-based restricted stock units (RSUs): 18,550 units tied to average annual adjusted EBITDA for 2024–2026 that may vest between 50% and 150% of target on February 22, 2027; 11,500 units tied to EBITDA for 2023–2025 that may vest between 75% and 115% on February 23, 2026; and 17,700 units tied to EBITDA for 2025–2027 that may vest between 50% and 150% on February 27, 2028, all based on actual performance.
Astronics Corp (ATRO) reported insider equity activity by its President and CEO, who is also a director. On 11/20/2025, he exercised stock options for 13,700 shares of $.01 par value common stock and 4,418 shares of $.01 par value Class B stock at an exercise price of $27.72 per share. To cover withholding taxes from the option exercise, 11,707 common shares were withheld at a price of $49.35 per share. Following these transactions, he beneficially owned 83,906.608 shares of common stock and 747,911 shares of Class B stock directly. The filing also lists multiple remaining stock option grants and restricted stock units that vest over future years based on Astronics’ average annual adjusted EBITDA performance metrics, with potential vesting between 50% and 150% of target. This Form 4 clarifies that these transactions are being reported on an original filing rather than an amendment.
Astronics Corp. (ATRO) President and CEO Peter J. Gundermann reported multiple equity transactions dated 11/20/2025. He exercised stock options to acquire 13,700 shares of $.01 par value common stock and 4,418 shares of $.01 par value Class B stock at an exercise price of $27.72 per share. To cover withholding taxes tied to the option exercise, 11,707 common shares were withheld at a price of $49.35 per share. Following these transactions, he directly owned 83,906.608 common shares and 747,911 Class B shares.
The filing also lists outstanding equity awards. These include multiple stock option grants with exercise prices ranging from $9.74 to $35.61 per share and expirations between 12/03/2025 and 12/07/2033, as well as several restricted stock unit awards tied to Astronics’ average annual adjusted EBITDA performance for periods running from 2023–2027, with potential vesting ranges between 50% and 150% of target on future dates.
Astronics Corp (ATRO) Executive VP & President–Aerospace Mark Peabody reported exercising stock options and acquiring company shares. On 11/19/2025, he exercised options to acquire 4,500 shares of $.01 par value common stock at $27.72 per share and 1,451 shares of $.01 par value Class B stock at $27.72 per share. Following these transactions, he beneficially owned 55,324.73 common shares and 185,445 Class B shares directly.
The filing also lists multiple option grants and restricted stock units. Several RSU awards vest based on Astronics’ average annual adjusted EBITDA over multi‑year periods ending December 31, 2025, December 31, 2026, and December 31, 2027, with between 50% and 150% (or 75% to 115% for one grant) of target units eligible to vest in February 2026, February 2027, and February 2028 based on actual performance.
Astronics Corp (ATRO)11/17/2025, she exercised stock options for a total of 3,600 shares of common and Class B stock at exercise prices of
After these transactions, she continued to hold Astronics common and Class B shares directly, as well as several blocks of restricted stock units (RSUs). These include 17,700, 5,024, and 5,050 RSUs, each representing the right to receive one share of common stock at settlement. Two RSU awards vest between
Astronics Corporation reported Q3 2025 results with sales of $211.4 million, up from $203.7 million a year ago. For the nine months, sales reached $622.1 million, and income from operations rose to $41.0 million, helping narrow the year-to-date net loss to $0.3 million. Operating cash flow improved to $47.2 million, reflecting better working capital trends.
The company refinanced and extended its capital structure: it issued $225.0 million zero-coupon 2031 convertible notes, partially repurchased $132.0 million of 2030 notes (recording a $32.6 million inducement loss), entered capped calls for $26.9 million, and ended the quarter with $85.0 million drawn on its ABL. Backlog was $646.7 million, with $479.2 million expected over the next twelve months.
Subsequent to quarter-end, Astronics acquired Bühler Motor Aviation for $18.0 million and replaced its ABL with a $300 million secured revolver maturing in 2030. During 2025, the company paid $21.6 million related to a UK legal matter. As of October 30, 2025, 35,629,121 shares were outstanding.
Astronics Corporation furnished an 8-K to announce its third quarter 2025 financial results. The company reported that a news release detailing the results is attached as Exhibit 99.1.
The information in this report, including Exhibit 99.1, is provided under Item 2.02 and is expressly stated as furnished, not filed, under the Exchange Act and Securities Act. The filing also includes Exhibit 104, the cover page interactive data file embedded within Inline XBRL.
Astronics Corp (ATRO) disclosed an insider equity transaction on a Form 4. Officer James Mulato (President, Astronics Test Systems) exercised stock options on 10/22/2025, acquiring 4,300 shares of $.01 par value Common Stock and 1,387 shares of $.01 par value Class B Stock at an exercise price of $27.72 per share.
Following these transactions, Mulato beneficially owned 36,811.822 shares of Common Stock and 2,453 shares of Class B Stock, held directly. The filing shows multiple remaining option grants with various exercise prices and expirations, as well as performance-based RSUs. Footnotes state that RSUs vest based on average annual adjusted EBITDA over specified multi-year periods, with vesting on stated dates tied to performance outcomes.
Astronics Corporation entered a new cash flow-based revolving credit agreement with HSBC, replacing its prior asset-based facility. The revolving commitments increased to $300.0 million from $220.0 million, with an option to request up to an additional $100.0 million plus an incremental amount, subject to leverage requirements. The facility matures on October 16, 2030.
Borrowings bear interest at Term SOFR plus a margin of 1.25%–2.125%, based on the Total Net Debt Leverage Ratio. Unused commitments incur a quarterly fee of 0.20%–0.35%. Certain subsidiaries guarantee the facility and their assets secure the obligations.
Astronics repaid all amounts under the terminated asset-based agreement using borrowings under the new facility, incurring no termination penalties. Key covenants include a Total Net Debt Leverage Ratio not exceeding 4.50x (up to 4.75x for the quarter ending December 31, 2025), a Consolidated Interest Coverage Ratio of at least 3.50x, and a Secured Net Debt Leverage Ratio not exceeding 3.00x.
FAQ
What is the current stock price of Astronics (ATRO)?
What is the market cap of Astronics (ATRO)?
